Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

625
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

583
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Centre for Veterinary Epidemiological Research at the Atlantic Veterinary College.

American journal of veterinary research·2026
Same author

Cleaning Product-Related Injuries Treated in US Emergency Departments: 2007-2022.

Pediatrics·2026
Same author

Risky social media challenges: a scoping review, 2000-2024.

Injury epidemiology·2025
Same author

Working donkey welfare assessment and owner survey in Meru County, Kenya.

Animal welfare (South Mimms, England)·2025
Same author

Characterizing Exposures to Methanol-based Hand Sanitizers During the COVID-19 Pandemic: Use of the National Poison Data System (NPDS) to Conduct Enhanced Surveillance During Response.

Disaster medicine and public health preparedness·2025
Same author

Draft horses have similar outcomes as nondraft horses presenting for colic at a referral institution in Atlantic Canada.

Journal of the American Veterinary Medical Association·2025

Related Experiment Video

Updated: Mar 7, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

11.1K

Pediatric Exposures to Veterinary Pharmaceuticals.

Suzanne Tomasi1,2, Kristin J Roberts3, Jason Stull2

  • 1Center for Injury Research and Policy, The Research Institute, and.

Pediatrics
|February 8, 2017
PubMed
Summary

Young children are most at risk for accidental veterinary medicine exposures. Most exposures are not serious, but awareness and safe storage can prevent them.

More Related Videos

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.4K
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

8.1K

Related Experiment Videos

Last Updated: Mar 7, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

11.1K
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.4K
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

8.1K

Area of Science:

  • Veterinary Toxicology
  • Pediatric Public Health
  • Pharmaceutical Epidemiology

Background:

  • Veterinary pharmaceuticals are increasingly accessible, raising concerns about accidental pediatric exposures.
  • Poison control centers are key resources for managing and tracking such incidents.

Purpose of the Study:

  • To analyze the epidemiology of veterinary pharmaceutical exposures in children.
  • To identify risk factors and common circumstances associated with these exposures.

Main Methods:

  • Retrospective analysis of pediatric cases (≤19 years) involving veterinary pharmaceuticals.
  • Data collected from a regional poison control center (1999-2013).
  • Review and coding of case narratives for exposure details and outcomes.

Main Results:

  • 1431 calls received for veterinary pharmaceutical exposures in children.
  • Children ≤5 years accounted for 87.6% of cases, with exploratory behavior being the primary circumstance.
  • Ingestion was the main exposure route (93%); common substances included unique veterinary drugs, antimicrobials, and antiparasitics.
  • Most exposures (96.9%) had no expected long-term effects and were managed at home (94.1%).

Conclusions:

  • Children under 5 are most vulnerable to veterinary pharmaceutical exposures.
  • While severe outcomes are rare, enhanced public awareness, proper dispensing, and secure storage are crucial for prevention.